Indications des ablations dans le traitement des arythmies cardiaques

详细信息    查看全文

• 作者：G. Moubarak (1) (2)
  F. Anselme (3)
  
  1. D茅partement de rythmologie ; groupe hospitalier Paris-Saint-Joseph ; 185 ; rue Raymond-Losserand ; F-75014 ; Paris ; France
  2. Service de cardiologie ; CHU Lariboisi猫re ; F-75010 ; Paris ; France
  3. Service de cardiologie ; CHU Charles-Nicolle ; F-76000 ; Rouen ; France
  
• 关键词：Ablation ; Arythmie cardiaque ; Radiofr茅quence ; Cryoablation ; Ablation ; Cardiac arrhythmia ; Radiofrequency ; Cryoablation
• 刊名：R篓娄animation
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：24
• 期：2
• 页码：172-182
• 全文大小：1,202 KB
• 参考文献：1. Biase, L, Burkhardt, JD, Santangeli, P (2014) Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation 129: pp. 2638-44 CrossRef
  2. Camm, AJ, Lip, GY, Caterina, R (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33: pp. 2719-47 CrossRef
  3. Haqqani, HM, Marchlinski, FE (2010) Creating lesions and indexing transmural ablation: pushing harder to find the Holy Grail. J Cardiovasc Electrophysiol 21: pp. 812-4
  4. Nath, S, DiMarco, JP, Haines, DE (1994) Basic aspects of radiofrequency catheter ablation. J Cardiovasc Electrophysiol 5: pp. 863-76 CrossRef
  5. Lustgarten, DL, Keane, D, Ruskin, J (1999) Cryothermal ablation: mechanism of tissue injury and current experience in the treatment of tachyarrhythmias. Prog Cardiovasc Dis 41: pp. 481-98 CrossRef
  6. Stewart, S, Hart, CL, Hole, DJ (2001) Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 86: pp. 516-21 CrossRef
  7. Camm, AJ, Kirchhof, P, Lip, GY (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31: pp. 2369-429 CrossRef
  8. Haissaguerre, M, Jais, P, Shah, DC (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339: pp. 659-66 CrossRef
  9. Wijffels, MC, Kirchhof, CJ, Dorland, R (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92: pp. 1954-68
  10. Jais, P, Cauchemez, B, Macle, L (2008) Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118: pp. 2498-505 CrossRef
  11. Wilber, DJ, Pappone, C, Neuzil, P (2010) Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 303: pp. 333-40 CrossRef
  12. Cosedis Nielsen, J, Johannessen, A, Raatikainen, P (2012) Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 367: pp. 1587-95 CrossRef
  13. Wazni, OM, Marrouche, NF, Martin, DO (2005) Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293: pp. 2634-40 CrossRef
  14. Arbelo, E, Brugada, J, Hindricks, G (2014) The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. Eur Heart J 35: pp. 1466-78 CrossRef
  15. Deshmukh, A, Patel, NJ, Pant, S (2013) In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation 128: pp. 2104-12 CrossRef
  16. Bunch, TJ, May, HT, Bair, TL (2013) Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. Heart Rhythm 10: pp. 1272-7 CrossRef
  17. Verma, A, Champagne, J, Sapp, J (2013) Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med 173: pp. 149-56 CrossRef
  18. Stabile, G, Bertaglia, E, Senatore, G (2006) Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 27: pp. 216-21 CrossRef
  19. Dixit, S, Marchlinski, FE, Lin, D (2012) Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol 5: pp. 287-94 CrossRef
  20. Packer, DL, Kowal, RC, Wheelan, KR (2013) Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 61: pp. 1713-23 CrossRef
  21. Metzner, A, Reissmann, B, Rausch, P (2014) One-year clinical outcome after pulmonary vein isolation using the secondgeneration 28-mm cryoballoon. Circ Arrhythm Electrophysiol 7: pp. 288-92 CrossRef
  22. Metzner, A, Rausch, P, Lemes, C (2014) The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon. J Cardiovasc Electrophysiol 25: pp. 466-70 CrossRef
  23. Wyse, DG, Waldo, AL, DiMarco, JP (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347: pp. 1825-33 CrossRef
  24. Brignole, M, Auricchio, A, Baron-Esquivias, G (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34: pp. 2281-329 CrossRef
  25. Sundt, TM, Camillo, CJ, Cox, JL (1997) The maze procedure for cure of atrial fibrillation. Cardiol Clin 15: pp. 739-48 CrossRef
  26. Calkins, H, Kuck, KH, Cappato, R (2012) 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14: pp. 528-606 CrossRef
  27. Boersma, LV, Castella, M, Boven, W (2012) Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation 125: pp. 23-30 CrossRef
  28. Olgin, JE, Kalman, JM, Fitzpatrick, AP (1995) Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography. Circulation 92: pp. 1839-48 CrossRef
  29. Anselme, F, Saoudi, N, Poty, H (1999) Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality-of-life evaluation in patients with proven isthmus block. Circulation 99: pp. 534-40 CrossRef
  30. Brembilla-Perrot, B, Filali, ML, Zinzius, PY (2012) Is ablation of atrial flutter always safe. Pacing Clin Electrophysiol 35: pp. 1061-6 CrossRef
  31. Blomstrom-Lundqvist, C, Scheinman, MM, Aliot, EM (2003) ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias鈥攅xecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation 108: pp. 1871-909 CrossRef
  32. Moubarak, G, Pavin, D, Laviolle, B (2009) Incidence of atrial fibrillation during very long-term follow-up after radiofrequency ablation of typical atrial flutter. Arch Cardiovasc Dis 102: pp. 525-32 CrossRef
  33. Akhtar, M, Jazayeri, MR, Sra, J (1993) Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations. Circulation 88: pp. 282-95 CrossRef
  34. Haissaguerre, M, Gaita, F, Fischer, B (1992) Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy. Circulation 85: pp. 2162-75 CrossRef
  35. Jackman, WM, Beckman, KJ, McClelland, JH (1992) Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 327: pp. 313-8 CrossRef
  36. Scheinman, MM, Huang, S (2000) The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 23: pp. 1020-8 CrossRef
  37. Deisenhofer, I, Zrenner, B, Yin, YH (2010) Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO Study): results from a large multicenter prospective randomized trial. Circulation 122: pp. 2239-45 CrossRef
  38. Krahn, AD, Manfreda, J, Tate, RB (1992) The natural history of electrocardiographic preexcitation in men. The Manitoba Follow-up Study. Ann Intern Med 116: pp. 456-60 CrossRef
  39. Hare, GF, Javitz, H, Carmelli, D (2004) Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol 15: pp. 759-70 CrossRef
  40. Hare, GF, Javitz, H, Carmelli, D (2004) Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardia. Heart Rhythm 1: pp. 188-96 CrossRef
  41. Atienza, F, Arenal, A, Torrecilla, EG (2004) Acute and longterm outcome of transvenous cryoablation of midseptal and parahissian accessory pathways in patients at high risk of atrioventricular block during radiofrequency ablation. Am J Cardiol 93: pp. 1302-5 CrossRef
  42. Klein, GJ, Bashore, TM, Sellers, TD (1979) Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 301: pp. 1080-5 CrossRef
  43. Obeyesekere, MN, Leong-Sit, P, Massel, D (2012) Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: a meta-analysis. Circulation 125: pp. 2308-15 CrossRef
  44. Cohen, MI, Triedman, JK, Cannon, BC (2012) PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm 9: pp. 1006-24 CrossRef
  45. Bakker, JM, Capelle, FJ, Janse, MJ (1988) Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 77: pp. 589-606 CrossRef
  46. Daubert, JP, Zareba, W, Cannom, DS (2008) Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51: pp. 1357-65 CrossRef
  47. Sacher, F, Roberts-Thomson, K, Maury, P (2010) Epicardial ventricular tachycardia ablation a multicenter safety study. J Am Coll Cardiol 55: pp. 2366-72 CrossRef
  48. Jais, P, Maury, P, Khairy, P (2012) Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation 125: pp. 2184-96 CrossRef
  49. Kuck, KH, Schaumann, A, Eckardt, L (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375: pp. 31-40 CrossRef
  50. Reddy, VY, Reynolds, MR, Neuzil, P (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357: pp. 2657-65 CrossRef
  51. Bunch, TJ, Weiss, JP, Crandall, BG (2014) Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. Heart Rhythm 11: pp. 533-40 CrossRef
  52. Mallidi, J, Nadkarni, GN, Berger, RD (2011) Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm 8: pp. 503-10 CrossRef
  53. Stevenson, WG, Wilber, DJ, Natale, A (2008) Irrigated radio-frequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 118: pp. 2773-82 CrossRef
  54. Aliot, EM, Stevenson, WG, Almendral-Garrote, JM (2009) EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 11: pp. 771-817 CrossRef
  55. Maury, P, Baratto, F, Zeppenfeld, K (2014) Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%. Eur Heart J 35: pp. 1479-85 CrossRef
  56. Movsowitz, C, Schwartzman, D, Callans, DJ (1996) Idiopathic right ventricular outflow tract tachycardia: narrowing the anatomic location for successful ablation. Am Heart J 131: pp. 930-6 CrossRef
  
• 刊物主题：Emergency Medicine; Anesthesiology; Intensive / Critical Care Medicine;
• 出版者：Springer Paris
• ISSN：1951-6959

文摘

Cardiac arrhythmias can be primitive or associated with a variety of cardiovascular conditions. Arrhythmias may be responsible for an important alteration of quality of life, syncope, heart failure, thromboembolic events, or sudden death. Their treatment includes antiarrhythmic medications and/or ablation. The choice is influenced by the type of arrhythmia, medical history, benefits and risks of each strategy in an individual patient, and patient preference. Ablation is the destruction of the cardiac structure responsible for the arrhythmia by using a source of energy which is usually radiofrequency and in some cases cryotherapy. We review the indications of ablation techniques in the treatment of atrial fibrillation, atrial flutter, atrioventricular nodal reentry, Wolff-Parkinson-White syndrome, and ventricular tachycardia.